{"altmetric_id":4698175,"counts":{"readers":{"mendeley":7,"citeulike":0,"connotea":0},"total":{"posts_count":1},"blogs":{"unique_users_count":1,"unique_users":[53749],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa4ec3cf058f6100029ba","authors":["Sam Brownback"],"doi":"10.1377\/hlthaff.26.5.1509","first_seen_on":"2015-10-28T22:21:20+00:00","issns":["1544-5208"],"journal":"Health Affairs","last_mentioned_on":1446055200,"links":["http:\/\/content.healthaffairs.org\/content\/26\/5\/1509"],"pdf_url":"http:\/\/content.healthaffairs.org\/content\/26\/5\/1509.full.pdf","pmid":"17848471","pubdate":"2007-09-01T00:00:00+00:00","publisher_subjects":[{"name":"Public Health And Health Services","scheme":"era"},{"name":"Applied Economics","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"subjects":["healthservicesresearch","publichealth"],"title":"Eliminating Neglected Diseases: Impact Of Published Paper","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/eliminating-neglected-diseases-impact-published-paper-9"},"altmetric_score":{"score":9,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":9},"context_for_score":{"all":{"total_number_of_other_articles":6500718,"mean":6.0222432796255,"rank":676538,"this_scored_higher_than_pct":89,"this_scored_higher_than":5790264,"rank_type":"exact","sample_size":6500718,"percentile":89},"similar_age_3m":{"total_number_of_other_articles":207324,"mean":10.26247137076,"rank":34632,"this_scored_higher_than_pct":83,"this_scored_higher_than":172357,"rank_type":"exact","sample_size":207324,"percentile":83},"this_journal":{"total_number_of_other_articles":3112,"mean":33.962018000643,"rank":1685,"this_scored_higher_than_pct":43,"this_scored_higher_than":1354,"rank_type":"exact","sample_size":3112,"percentile":43},"similar_age_this_journal_3m":{"total_number_of_other_articles":96,"mean":55.562715789474,"rank":65,"this_scored_higher_than_pct":32,"this_scored_higher_than":31,"rank_type":"exact","sample_size":96,"percentile":32}}},"demographics":{"users":{"mendeley":{"by_status":{"Researcher":2,"Other":2,"Student  > Master":2,"Professor":1},"by_discipline":{"Medicine and Dentistry":3,"Chemistry":1,"Economics, Econometrics and Finance":1,"Agricultural and Biological Sciences":2}}},"geo":{"mendeley":{"BR":1,"GB":1}}},"posts":{"blogs":[{"title":"The Regulatory Burden Of The Priority Review Voucher Program","url":"http:\/\/healthaffairs.org\/blog\/2015\/10\/28\/the-regulatory-burden-of-the-priority-review-voucher-program\/","license":"public","citation_ids":[2357505,4698175],"posted_on":"2015-10-28T18:00:00+00:00","summary":"In a recent interview, an official from the Food and Drug Administration (FDA) expressed concern about the costs to the FDA of the priority review voucher program. The director of the Office of New Drugs said he&rsquo;s worried the additional priority revi","author":{"name":"Health Affairs Blog","url":"http:\/\/healthaffairs.org\/blog","description":"The Policy Journal of the Health Sphere"}}]}}